Product
RC148
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of RC148 in Patients With Locally Advanced Unresectable or Metastatic Solid Tumors: an Open-Label, Multicenter, Phase I TrialStatus: Recruiting, Estimated PCD: 2024-12-31